Role of noradrenergic signaling by the nucleus tractus solitarius in mediating opiate reward

Science

Volumn 311, Issue 5763, 2006, Pages 1017-1020

  Olson, Valerie G ^a,c   Heusner, Carrie L ^a   Bland, Ross J ^b   During, Matthew J ^b,d   Weinshenker, David ^a,e   Palmiter, Richard D ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b Neurologix Inc   (United States)

^c VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^d OHIO STATE UNIVERSITY   (United States)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIPED LOCOMOTION; BRAIN; ENZYMES; HYDROXYLATION;

NORADRENERGIC SIGNALING; NOREPINEPHRINE; NUCLEUS TRACTUS; OPIATE REWARD;

NEUROLOGY;

DOPAMINE BETA MONOOXYGENASE; MORPHINE; NORADRENALIN; OPIATE;

BIOLOGY;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; KNOCKOUT MOUSE; LOCOMOTION; LOCUS CERULEUS; NONHUMAN; NORADRENERGIC SYSTEM; PLACE PREFERENCE; PRIORITY JOURNAL; REWARD; SIGNAL TRANSDUCTION; SOLITARY TRACT NUCLEUS;

ANIMALS; BEHAVIOR, ANIMAL; CONDITIONING (PSYCHOLOGY); DOPAMINE BETA-HYDROXYLASE; DROXIDOPA; LOCOMOTION; LOCUS COERULEUS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MORPHINE; MOTOR ACTIVITY; NOREPINEPHRINE; REWARD; SIGNAL TRANSDUCTION; SOLITARY NUCLEUS; SYNAPTIC TRANSMISSION;

ANIMALIA;

EID: 33144478267     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.1119311     Document Type: Article

References (30)

1. W. M. Davis, S. G. Smith, J. H. Khalsa, Pharmacol. Biochem. Behav. 3, 477 (1975).
2. L. Stein, in Psychopharmacology: A Generation of Progress, M. A. Lipton, A. DiMascio, K. F. Killam, Eds. (Raven, New York, 1978), pp. 569-581.
3. R. Maldonado, Neurosci Biobehav. Rev. 21, 91 (1997).
4. S.A. Thomas, B.T. Marck, R. D. Palmiter, A. M. Matsumoto, J. Neurochem. 70, 2468 (1998).
5. S. A. Thomas, A. M. Matsumoto, R. D. Palmiter, Nature 374, 643 (1995).
6. T. M. Tzschentke, Prog. Neurobiol. 56, 613 (1998).
7. J. R. Schank et al., Neuropsychopharmacology, published online 14 December 2005 (10.1038/sj.npp.1301000).
8. R. Ventura, A. Alcaro, S. Puglisi-Allegra, Cereb. Cortex 15, 1877 (2005).
9. C. Drouin, G. Blanc, F. Trovero, J. Glowinski, J. P. Tassin, Neuroreport 12, 3483 (2001).
10. C. Drouin et al., J. Neurosci. 22, 2873 (2002).
11. T. S. Hnasko, B. N. Sotak, R. D. Palmiter, Nature 438, 854 (2005).
12. J. M. Delfs, Y. Zhu, J. P. Druhan, G. Aston-Jones, Nature 403, 430 (2000).
13. V. G. Olson, R. D. Palmiter, data not shown.
14. R. Y. Moore, F. E. Bloom, Annu. Rev. Neurosci. 2, 113 (1979).
15. J. M. Delfs, Y. Zhu, J. P. Druhan, G. S. Aston-Jones, Brain Res. 806, 127 (1998).
16. P. M. Milner, Can. J. Psychol. 45, 1 (1991).
17. M. R. Zarrindast, T. Bahreini, M. Adl, Pharmacol. Biochem. Behav. 73, 941 (2002).
18. H. Sahraei et al., Pharmacol. Biochem. Behav. 78, 135 (2004).
19. K. Nader, D. van der Kooy, Behav. Neurosci. 110, 389 (1996).
20. M. J. Christie, J. T. Williams, P. B. Osborne, C. E. Bellchambers, Trends Phamacol. Sci. 18, 134 (1997).
21. M. Spreng, S. Cotecchia, F. Schenk, Neurobiol. Learn. Mem. 75, 214 (2001).
22. J. Knauber, W. E. Muller, Eur. Neuropsychopharmacol. 10, 423 (2000).
23. A. Auclair, C. Drouin, S. Cotecchia, J. Glowinski, J. P. Tassin, Eur. J. Neurosci. 20, 3073 (2004).
24. A. F. Arnsten, B. M. Li, Biol. Psychiatry 57, 1377 (2005).
25. M. L. Laorden, M. T. Castells, M. V. Milanes, Br. J. Pharmacol. 136, 67 (2002).
26. T. Watanabe et al., Psychopharmacology 170, 80 (2003).
27. X. Wang, X. Cen, L. Lu, Eur. J. Pharmacol. 432, 153 (2001).
28. Y. Shaham, D. Highfield, J. Delfs, S. Leung, J. Stewart, Eur. J. Neurosci. 12, 292 (2000).
29. J. Grenhoff, M. Nisell, S. Ferre, G. Aston-Jones, T. H. Svensson, J. Neural Transm. Gen. Sect 93, 11 (1993).
30. We thank W. Curtis for maintaining the DBH mouse colony, Sumitomo Pharmaceutical for DOPS, C. Hutter for statistical advice, P. M. Tran for technical assistance, and our colleagues for constructive suggestions. Supported by an NIH National Research Service Award grant (V.G.O.) and an institutional Program Project grant from the National Institute on Drug Abuse.